Think of a vaccination card as a small piece of social memory. It records a shot, but it also records a promise a country makes to itself: that children will not grow up fearing a disease their grandparents learned to dread. Brazil once held that promise firmly. In 2016, the Pan American Health Organization certified the country as having eliminated endemic measles transmission. It was an extraordinary achievement, the result of decades of vaccination campaigns, community health workers, and a unified public health system that reached people in cities, villages, and remote river communities. Three years later, the virus returned and spread across the country, and Brazil lost the status it had worked so hard to earn. In November 2024, the country regained its certification, and the relief was genuine. But the relief did not last. In 2026, São Paulo state has confirmed twenty-three measles cases, twenty of them in the city of São Paulo, with additional infections in São Bernardo do Campo and Guarulhos. That is a sharp increase from just two cases during all of 2025. The numbers are tiny compared with the massive outbreaks that once swept through Brazil, but measles has never been a disease that respects small numbers. It is among the most contagious infections on earth. One sick person can infect up to nine out of ten unprotected people around them. The virus can hang in the air for up to two hours after an infected person has left the room. It can cause pneumonia, brain inflammation, and death. There is no cure, only prevention. Health authorities in the three affected municipalities have responded by recommending measles vaccination for everyone between six months and fifty-nine years old, regardless of previous vaccination history. That recommendation is an admission of uncertainty. It means the system no longer trusts old records, good intentions, or faded memories to protect people. It wants fresh immunity, and it wants it now.
The return of measles is not just a public health alert. It is a warning about what happens when a society takes its victories for granted. Brazil knows how to prevent measles. The infrastructure exists, and the science is clear. What has become less clear is the social agreement behind vaccination. Measles is an unforgiving indicator of weaknesses in collective immunity. When vaccination coverage falls below the level needed to interrupt transmission, a single imported infection can find a population increasingly vulnerable to it. For measles, public health experts generally consider a coverage rate of around 95 percent necessary to maintain the collective protection that prevents sustained transmission. That is not an arbitrary number. It is the mathematical point at which the virus cannot find enough susceptible people to keep jumping from one host to another. In Brazil, the story of that erosion is documented with painful clarity. According to estimates from the World Health Organization and UNICEF, coverage for the first measles-containing vaccine dose fell from 97 percent in 2014 to 73 percent in 2021. It recovered to 90 percent in 2023, rose to 96 percent in 2024, and then slipped back to 90 percent in 2025. These national averages can look abstract, but they are made of millions of individual stories: children who missed appointments, families who moved and lost track of vaccination schedules, parents who hesitated, clinics that were hard to reach, and years of political noise that made basic questions seem complicated. The Brazilian Federal Council of Medicine warned in late 2025 that national vaccination coverage for several important vaccines had remained around 85 percent, well below the 95 percent target. That gap is not a rounding error. It is exactly the kind of opening through which a highly contagious virus can slip.
Brazil’s vaccination crisis did not begin with Covid-19. Childhood vaccination coverage had been declining for years, with a particularly sharp deterioration after 2015. According to the VacinaBR yearbook, produced by the Instituto Questão de Ciência with support from the Brazilian Society of Pediatrics and Immunization and in partnership with UNICEF, the decline affected vaccines across the entire childhood immunization schedule. There was good news after the pandemic: coverage began to recover in 2022 and improved significantly in 2023. But even then, no childhood vaccine reached the national target in every Brazilian state. The deeper problem is not simply that people stopped believing in vaccines. It is that vaccines became less visible precisely because they worked. For a generation of Brazilians, measles is a historical footnote, not a lived memory. They have not watched a child gasp for air in an isolation ward. They have not listened to a doctor explain that there is nothing to do but wait and pray. The disease has become abstract, a word in an old textbook. The vaccine, meanwhile, remains tangible. It is a needle, a sore arm, a trip to the health post, a possible side effect that triggers anxious internet searches. The success of immunization has created its own paradox: the better the vaccines work, the easier it is to forget why they are necessary. This is not a uniquely Brazilian problem, but Brazil feels it sharply because it built one of the most impressive vaccination systems in the world. That system depends on a kind of civic faith: people must show up even when they see no immediate threat. When the threat is invisible, the effort can seem pointless. And when political leaders treat that effort as a matter of ideology, the faith can be replaced by suspicion.
During the Covid-19 pandemic, vaccination lost its neutral status. It stopped being something you simply did at the health center and became a statement about authority, freedom, science, institutions, and political identity. In Brazil, this transformation was especially visible during the presidency of Jair Bolsonaro. He frequently advocated for freedom, opposed mandatory vaccination, and downplayed the risks of the pandemic. In June 2021, he incorrectly described the Covid-19 vaccines being administered in Brazil as still experimental, despite regulatory authorization and strong clinical evidence supporting their use. He said he would decide whether to take a vaccine only after the rest of the Brazilian population had been vaccinated. These statements mattered not only because they came from a president, but because political leaders provide what researchers call informational cues: signals that help people interpret complicated issues when they do not have the technical knowledge to evaluate the evidence themselves. If a trusted leader treats vaccines as suspicious, then accepting or rejecting a vaccine can become a way of expressing loyalty. Studies in Brazil found exactly this pattern. Research published in Frontiers in Political Science showed that supporters of Bolsonaro were more likely to accept misinformation and conspiracy theories about Covid-19. An ecological study of Brazilian municipalities found an association between support for Bolsonaro and lower Covid-19 vaccination uptake, even after adjusting for social and economic factors. On social media, the divide was stark. A study examining more than one million tweets and four million retweets found clearly divided pro- and anti-vaccine communities, with anti-vaccine actors successfully framing the pandemic through populist, anti-science, and anti-establishment narratives. Another study found that false information about Covid-19 vaccines spread widely across Instagram, Facebook, Twitter, and WhatsApp, closely linked to the country’s political polarization.
This does not mean that every person who hesitates over a vaccine is politically motivated. Vaccine hesitancy has many causes: fear of side effects, lack of information, distrust in institutions, difficulty accessing health services, complacency, and simple forgetfulness. What the pandemic added was a new layer of complexity. It made vaccination a cultural identity marker for some people, a way of saying who they trusted and who they opposed. The post-pandemic inheritance in Brazil is not a country suddenly converted to anti-vaccine ideology. It is a population whose relationship with vaccination has become more complicated, less automatic, less institutional, and more susceptible to political and cultural cues. A national survey reported by Rádio Senado found that 72.1 percent of respondents said they kept their vaccinations up to date. But 9.9 percent said they did not get vaccinated at all, and another 9.2 percent said they had stopped vaccinating during the pandemic. Among people aged sixteen to twenty-four, only 62.9 percent reported keeping their vaccinations current; among those aged twenty-five to thirty-four, the figure was 62 percent. These are not older people clinging to old habits. They are young adults who grew up in an era of institutional rupture, misinformation, and loss of perceived risk. The survey’s coordinator, researcher Pedro Arantes of the Federal University of São Paulo, linked part of the decline to misinformation generated during the pandemic and to a weakening sense that these diseases are worth fearing. When a disease is no longer visible, the vaccine can seem optional. And when the vaccine seems optional, the collective immunity that protects everyone begins to fray.
There is a temptation to describe the current moment as a battle between science and anti-science. That framing is emotionally satisfying, but it is incomplete. The deeper issue is trust. A person who refuses a vaccine because of a false claim circulating on social media is responding to information. But a person who accepts that claim instead of information from a doctor, a public health agency, or a scientific institution is also making a judgment about whom to trust. The pandemic exposed how fragile that trust can become when political leaders, institutions, and experts send conflicting messages. It also showed that polarization does not have to last forever. Research tracking Covid-19 vaccination in Brazil found that the initial gap in adherence between conservatives and non-conservatives narrowed over time, largely because many people who had initially been skeptical eventually got vaccinated. That finding matters. It suggests that political identity does not permanently determine vaccine behavior. People can change their minds, especially when they see the consequences of refusing protection. But rebuilding confidence is slower than destroying it. Trust takes years to build and can be shattered in a few careless speeches. The virus does not care about political timelines. It simply waits for the gaps in immunity to grow wide enough. What measles is really exposing in Brazil is not a population that has abandoned science. It is a public health system that must compete with a fragmented information environment, a polarized political culture, and the natural human tendency to believe that a problem solved is a problem gone forever. Brazil has the infrastructure to protect its people. It has one of the world’s largest public immunization programs, and it has recovered much of the ground lost during the pandemic. The latest international data show the country moving in the right direction, even if national averages can hide local vulnerabilities. A few percentage points of lost coverage may look insignificant on a spreadsheet. But in a densely populated city connected to the rest of the world by airports, those missing vaccinations become corridors through which a highly contagious virus can move. The return of measles should not be read as evidence that Brazilians have become anti-vaccine, nor should it be dismissed as an isolated consequence of international travel. It is a warning about what happens when public health achievements are taken for granted, when misinformation becomes politically profitable, and when scientific questions become symbols of political loyalty. The most important question is not whether vaccination in Brazil is left-wing or right-wing. It is whether vaccination can become politically uninteresting again, a routine act of care that no one needs to debate. That may be the only way to keep measles out of Brazil’s future.